Term
selective NE reuptake inhibitor |
|
Definition
|
|
Term
|
Definition
clonidine and guanifacine ER |
|
|
Term
others drugs used in ADHD |
|
Definition
anticonvulsants, lithium and bupropion |
|
|
Term
atypical antipsychotics (dopamine antagonists) |
|
Definition
rispiridone, Geodon (ziprasodone), Zyprexa (olanzapine), Abilify (aripiprazol) |
|
|
Term
first and second line for ADHD |
|
Definition
methylphenidate or dexmethylphenidate switched with dextroamphetamine or mexed amphet salts |
|
|
Term
|
Definition
atomoxetine (Strattera), guanfacine ER, clonidine or bupropion |
|
|
Term
|
Definition
consider combo of first-third line agents or TCA |
|
|
Term
First line for Tourrette's disorder comorbidity |
|
Definition
atypical antipsychotic, lithium, anticonvulsant |
|
|
Term
response to first line but ADHD persists for Tourrette's disorder comorbidity |
|
Definition
|
|
Term
inadequate response for Tourrette's disorder comorbidity |
|
Definition
alternative or additional mood stabilizer |
|
|
Term
First line for anxiety/depression disorder comorbidity |
|
Definition
psychotherapy and antidepressant |
|
|
Term
response to first line but for anxiety/depression disorder comorbidity |
|
Definition
|
|
Term
inadequate response for anxiety/depression disorder comorbidity |
|
Definition
alternative antidepressant |
|
|
Term
first line for bipolar/ severe aggression comorbidity |
|
Definition
atypical antipsychoits, lithium or anticonvulsant |
|
|
Term
Response by ADHD persists for bipolar/ severe aggression comorbidity |
|
Definition
|
|
Term
inadequate response for bipolar/ severe aggression comorbidity |
|
Definition
alternative or additional mood stabilizer |
|
|
Term
|
Definition
ritalin, methylin, focalin, dexadrine, dextrostat |
|
|
Term
|
Definition
ritalin SR, methylin ER, metadate ER, methylphenidate ER, dexadrine spansule, adderall |
|
|
Term
|
Definition
ritalin LA, metadate CD, methylphenidate transdermal, daytrana, adderall, concerta |
|
|
Term
|
Definition
uses oral osmotic CR delivery, other preps use IR and ER beads |
|
|
Term
|
Definition
provides 12 hours of symptom control when worn for 9 hours, apply patch 2 hours before desired effect |
|
|
Term
older wax matrix (ritalin) |
|
Definition
less effective and not used as much |
|
|
Term
|
Definition
selective NE reuptake inhibitor, the first to be approved for ADHD |
|
|
Term
no potential for abuse, but slower onset |
|
Definition
|
|
Term
alpha-2 antagonists (guanfacine/clonidine) |
|
Definition
less effective alternatives to stimulant, atomoxetine and bupropion monotherapy (good for adjunct to reduce disruptive behavior, control aggression and improve sleep) |
|
|
Term
|
Definition
used increasingly to control aggression and explosive behavior |
|
|
Term
|
Definition
controls severe aggression in refractory cases of ADHD, especially if conduct disorder or bipolar disorder comorbidity is present |
|
|
Term
conventional antipsychotics |
|
Definition
not used that frequently now that we have atypical antipsychotics |
|
|
Term
BBW of new onset suicidality |
|
Definition
strattera and TCA (children/adolescents) |
|
|
Term
BBW of psychosis/mania, aggression/violent behavior, severe anxiety or panic attacks |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
atomoxetine carries warning for this |
|
|
Term
cardiac sudden death in children and adults |
|
Definition
|
|
Term
stimulants SE mitigation: reduced appetite/ wt loss |
|
Definition
high calorie meal when stimulant effects are low (breakfast and bedtime) |
|
|
Term
stimulants SE mitigation: stomach ache |
|
Definition
give on full stomach and lower dose if possible |
|
|
Term
stimulants SE mitigation: insomnia |
|
Definition
give dose earlier in day; lower the first dose of day or give it earlier; consider a sedating medication at bedtime |
|
|
Term
stimulants SE mitigation: HA |
|
Definition
divide dose, give with food or give analgesic (tyleno, advil) |
|
|
Term
stimulants SE mitigation: rebound symptoms |
|
Definition
consider long-acting stimulant trial, atomoxetine or antidepressant |
|
|
Term
sedating meds at bedtime if needed for stimulant effects |
|
Definition
guanfacine, clonidine, melatonin, or cyproheptadine |
|
|
Term
stimulants SE mitigation: irritability/jitteriness |
|
Definition
assess for comorbid condition (bipolar disorder), reduce dose, consider mood stabilizer (lithium, valproate) or atypical antipsychotic |
|
|
Term
stimulants SE mitigation: zombie-like |
|
Definition
reduce dose and consider alt therapy |
|
|
Term
stimulants SE mitigation: hypertension, pulse fluctuations or dysphoria |
|
Definition
reduce dose or change med |
|
|
Term
stimulants SE mitigation: hallucinations |
|
Definition
discontinue stimulant, reassess diagnosis, mood stabilizer and/ or atypical antipsychotic may be needed |
|
|